Executive Summary
Eagle Materials is a vertically integrated US producer of heavy and light building materials: Portland cement (7 plants, 8M+ tons capacity), gypsum wallboard (5 plants, 5th largest US producer), concrete/aggregates, and recycled paperboard. Headquartered in Dallas, TX, the company operates 70+ facilities across 21 states. Seth Klarman's Baupost Group increased its position by ~39% to 4.64% of portfolio ($221M), despite an estimated 22% unrealized loss -- signaling deep conviction in the cyclical setup.
PHASE 1: RISK ASSESSMENT
1.1 Business Model Risk
Cyclicality (HIGH): EXP is deeply cyclical, tied to US housing starts (wallboard) and infrastructure/non-residential construction (cement). During the GFC, EPS collapsed from $4.06 (FY2007) to $0.34 (FY2011) -- an 92% decline. Revenue fell from ~$1.2B to ~$495M. This is not a business that grows smoothly.
Current Cycle Position: Wallboard is in a downturn (volume -14% YoY in Q3 FY2026), while cement is strong (+9% volume). This split cycle is unusual and reflects elevated mortgage rates depressing residential starts while IIJA infrastructure spending remains robust.
Commodity Exposure: Both wallboard and cement are commodity products. Pricing power exists only when supply is tight. Wallboard prices fell 5% YoY in Q3 FY2026 to $225/MSF. Cement prices dipped 1%.
1.2 Financial Risk
Leverage: Net debt $1.4B, net leverage 1.8x EBITDA (up from 1.5x in FY2025 after $750M senior notes issuance in Nov 2025). This is manageable but watch-worthy given cyclicality.
Debt Structure: $750M 5% Senior Notes due 2036 + existing facilities. $1.2B committed liquidity. Adequate for current cycle.
Interest Coverage: EBITDA ~$731M TTM vs ~$60M interest expense = ~12x coverage. Comfortable.
1.3 Structural/Secular Risks
- Housing Affordability: Persistently elevated mortgage rates (6.5-7%) are depressing single-family starts, the key wallboard demand driver. No near-term catalyst for improvement.
- Tariff Risk: Cement imports could face tariffs, but EXP is 100% domestic producer -- this is actually a tailwind as imported cement becomes more expensive.
- Energy Costs: Cement production is energy-intensive. Natural gas price spikes compress margins. The $330M Duke plant modernization targets 20% manufacturing cost reduction partly through lower gas consumption.
- Environmental/Carbon: Cement is a major CO2 emitter. Future carbon regulations could increase costs, though US policy trajectory is unclear.
1.4 Risk Verdict
MODERATE-HIGH cyclical risk, MODERATE financial risk. The business survived the GFC (barely) and has since built a stronger balance sheet. Current wallboard weakness is cyclical, not structural. Cement infrastructure tailwinds provide a partial hedge. The 1.8x leverage is elevated for a cyclical but manageable with $550M+ operating cash flow.
PHASE 2: FINANCIAL ANALYSIS
2.1 Income Statement (5-Year Trend, Fiscal Year Ends March)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | 5yr CAGR |
|---|---|---|---|---|---|---|
| Revenue ($M) | 1,623 | 1,862 | 2,148 | 2,259 | 2,261 | 8.6% |
| Gross Profit ($M) | 408 | 520 | 639 | 685 | 673 | 13.3% |
| Gross Margin | 25.2% | 27.9% | 29.8% | 30.3% | 29.8% | - |
| Operating Income ($M) | 359 | 473 | 586 | 626 | 599 | 13.6% |
| Operating Margin | 22.1% | 25.4% | 27.3% | 27.7% | 26.5% | - |
| Net Income ($M) | 339 | 374 | 462 | 478 | 463 | 8.1% |
| EPS (Diluted) | $7.09 | $9.41 | $12.67 | $13.79 | $13.85 | 18.2% |
| EBITDA ($M) | 598 | 635 | 763 | 811 | 793 | 7.3% |
Key Observations:
- Revenue nearly flat FY2024 to FY2025 ($2,259M vs $2,261M), but EPS grew due to buybacks.
- EPS CAGR of 18.2% is impressive, driven by 8.6% revenue growth + margin expansion + aggressive share reduction (shares declined from ~42M to ~33.6M, a 20% reduction in 5 years).
- Operating margins consistently above 22%, peaking at 27.7% -- excellent for a building materials company.
- SG&A remarkably lean at just 3.3% of revenue ($74M on $2.26B revenue). This is a hallmark of a well-run, low-overhead industrial.
2.2 TTM Performance (Trailing 4 Quarters through Dec 2025)
| Metric | TTM |
|---|---|
| Revenue | $2,300M |
| EPS (Diluted) | $13.22 |
| EBITDA | ~$732M |
| Operating Margin | 24.6% |
| Net Margin | 18.7% |
Revenue essentially flat but earnings pressured by wallboard weakness. Q3 FY2026 EPS of $3.22 missed estimates of $3.49 by 7.7%.
2.3 Balance Sheet
| Metric | FY2025 (Mar) | Q3 FY2026 (Dec) |
|---|---|---|
| Total Assets | $3,265M | ~$3,800M (est.) |
| Total Equity | $1,457M | ~$1,450M |
| Total Debt | $1,276M | ~$1,800M |
| Net Debt | $1,256M | ~$1,400M |
| Cash | $20M | ~$400M |
| Net Debt/Equity | 0.86x | ~0.97x |
| Net Debt/EBITDA | 1.6x | 1.8x |
| Book Value/Share | $43.30 | ~$47.33 |
Notable: The $750M notes issuance in Nov 2025 significantly increased gross debt, but the company holds ~$400M+ cash and has $1.2B committed liquidity. The debt funds capex (Duke $330M expansion, Mountain Cement investments) and ongoing buybacks.
2.4 Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating CF ($M) | 643 | 517 | 542 | 564 | 549 |
| CapEx ($M) | 54 | 74 | 110 | 120 | 195 |
| Free Cash Flow ($M) | 589 | 443 | 432 | 444 | 354 |
| FCF Margin | 36.3% | 23.8% | 20.1% | 19.6% | 15.7% |
| Buybacks ($M) | 4 | 595 | 394 | 354 | 304 |
| Dividends ($M) | 4 | 31 | 37 | 35 | 34 |
| Total Shareholder Return ($M) | 8 | 626 | 431 | 389 | 338 |
Key Observations:
- Massive buyback machine: $1.65B in buybacks over 4 years (FY2022-FY2025), reducing shares from ~42M to ~33.6M (20% reduction).
- FCF margin declining due to elevated capex ($195M FY2025 vs $54M FY2021) for growth investments. This is good capex -- plant modernization/expansion with clear return targets.
- Dividend small but growing ($1.00/share, 0.5% yield). The company prefers buybacks for capital return -- correct approach for a cyclical at reasonable valuations.
- OCF consistently above $500M -- extremely strong cash generation for a ~$6.5B market cap company.
2.5 Returns on Capital
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| ROE | 25.0% | 33.0% | 38.9% | 36.5% | 31.8% |
| ROA | 11.9% | 14.5% | 16.6% | 16.2% | 14.2% |
| ROIC (est.) | ~22% | ~27% | ~30% | ~29% | ~26% |
Exceptional returns. ROE consistently above 25%, ROIC well above 20%. Passes the Buffett ROE test (>15%) with flying colors. These returns are real -- driven by operational efficiency, not just leverage (ROA also strong at 14-17%).
2.6 Buffett Financial Test
| Test | Threshold | EXP | Pass? |
|---|---|---|---|
| ROE > 15% | 15% | 31.8% | YES |
| Debt/Equity < 1.0 | 1.0x | 0.97x | BORDERLINE |
| Operating Margin > 15% | 15% | 26.5% | YES |
| FCF Positive | >0 | $354M | YES |
| Consistent Earnings Growth | 5yr+ | 18.2% EPS CAGR | YES |
| Share Buybacks | Active | $1.65B/4yr | YES |
5 of 6 tests passed. Leverage is borderline but justified by capex cycle and strong coverage ratios.
PHASE 3: MOAT ASSESSMENT
3.1 Moat Sources
1. Regional Cost Advantage (PRIMARY - STRONG)
- Cement and wallboard are heavy, low-value-per-ton products. Transportation costs are a massive % of delivered cost (~$30-50/ton for cement trucking 100+ miles). This creates natural regional monopolies/oligopolies.
- Eagle operates 70+ facilities across 21 states, strategically located near demand centers. ~70% of revenue comes from 10 core states.
- The Duke, Oklahoma wallboard modernization ($330M) will cut manufacturing costs by 20% and sits near decades of low-cost natural gypsum reserves.
- Cement plants sit on captive limestone reserves -- irreplaceable.
2. Vertical Integration (MODERATE)
- Eagle is vertically integrated: owns raw material deposits (gypsum, limestone), manufactures products, and controls distribution.
- Recycled paperboard operation uses waste paper to produce linerboard for wallboard -- reduces input costs and waste.
3. Barriers to Entry (STRONG)
- New cement plant costs $500M-$1B+ and takes 3-5 years to permit and build. Environmental permits are extremely difficult to obtain in the US.
- Gypsum wallboard plants: $300M+ for a modern facility (evidenced by the Duke expansion).
- No new US cement capacity has been greenfield-built in decades due to permitting difficulty. Existing plants are irreplaceable assets.
4. Capacity Discipline (MODERATE)
- US wallboard industry has historically maintained reasonable supply/demand balance. The top 5 producers control ~85%+ of the market.
- Cement supply in EXP's markets is tight, with imports filling the gap. Tariffs on imports would benefit domestic producers.
3.2 Moat Width and Durability
Width: NARROW-TO-MODERATE
- Not a wide moat -- commodity products, cyclical demand, no pricing power in downturns.
- But regional cost advantages and barriers to entry create meaningful economic protection.
- The moat is structural (geography, assets, permits) rather than brand/network based.
Durability: 15+ years
- Physical assets (quarries, plants) do not become obsolete. Cement and gypsum wallboard have no substitutes for core construction use.
- Permitting barriers are getting harder, not easier -- moat widening over time.
3.3 Competitive Position
- Cement: 7th largest US producer, 8M+ tons capacity. Regional #1-#3 in key markets (Texas, Midwest, Mountain West).
- Wallboard: 5th largest US producer. Expanding capacity by 25% at Duke plant.
- Combined: The dual-segment structure provides some cycle diversification (infra cement vs. residential wallboard).
PHASE 4: VALUATION AND SYNTHESIS
4.1 Current Valuation
| Metric | Value |
|---|---|
| Share Price | ~$201 |
| Market Cap | ~$6.5B |
| P/E (TTM) | 15.2x |
| P/E (Forward est.) | 14.9x |
| EV/EBITDA | 10.0x |
| P/B | 4.2x |
| FCF Yield (norm.) | ~6.5% |
| Dividend Yield | 0.5% |
| P/S | 2.8x |
4.2 Historical EPS and Cyclical Analysis
| Period | EPS | P/E at $201 |
|---|---|---|
| FY2025 (peak-ish) | $13.85 | 14.5x |
| TTM (Dec 2025) | $13.22 | 15.2x |
| FY2024 | $13.79 | 14.6x |
| FY2023 | $12.67 | 15.9x |
| FY2022 | $9.41 | 21.4x |
| Mid-cycle norm. (est.) | ~$11.00 | 18.3x |
| Trough (est.) | ~$6.00-7.00 | 28.7-33.5x |
Critical cyclical context: Current EPS of ~$13 is near-peak. A housing downturn could easily cut wallboard earnings in half. Mid-cycle normalized EPS is ~$11, making the current P/E on normalized earnings ~18x -- not cheap for a cyclical.
4.3 DCF Valuation (10-Year)
Base Case Assumptions:
- Normalized FCF: ~$400M (avg FY2022-FY2025, adjusted for higher capex cycle)
- Growth rate: 4% (GDP + share reduction + price increases)
- Terminal multiple: 10x EBITDA
- Discount rate: 10%
- Net debt: $1.4B
| Scenario | Normalized FCF | Growth | Fair Value/Share |
|---|---|---|---|
| Bull (housing recovery) | $500M | 6% | $280-310 |
| Base (muddle through) | $400M | 4% | $210-240 |
| Bear (recession) | $250M | 2% | $130-160 |
| Deep Bear (GFC repeat) | $150M | 0% | $80-100 |
4.4 Comparable Valuation
| Company | EV/EBITDA | P/E | ROE |
|---|---|---|---|
| Summit Materials (SUM) | 12.5x | 22x | 8% |
| Martin Marietta (MLM) | 16x | 28x | 14% |
| Vulcan Materials (VMC) | 18x | 32x | 12% |
| Eagle Materials (EXP) | 10.0x | 15.2x | 28.8% |
Eagle trades at a significant discount to aggregates peers (MLM, VMC) despite much higher returns on capital. This reflects the market's cyclical concern about wallboard and EXP's smaller size/lower trading liquidity.
4.5 Fair Value Estimate
- Base case fair value: $220-240/share (18-20x mid-cycle EPS of ~$12)
- Strong Buy price: $165 (15x trough-to-mid-cycle EPS of $11, or ~25% margin of safety to base case)
- Accumulate price: $190 (17x mid-cycle, ~15% margin of safety)
- Current price: ~$201 (16% below 52-week high of $243, 17% above 52-week low of $172)
4.6 Klarman Thesis (Inferred)
Klarman bought ~1.19M shares at an estimated average of ~$238 (now underwater ~22%). His 39% increase signals he views the decline as opportunity, not thesis-breaking. Likely thesis:
- Cyclical trough in wallboard creates entry opportunity. Housing starts at multi-decade lows will eventually recover.
- Infrastructure tailwinds for cement are durable. 60% of IIJA funds remain unspent.
- Capital allocation is exceptional. 20% share reduction in 4 years at reasonable prices.
- Asset replacement value far exceeds market cap. 7 cement plants + 5 wallboard plants + 70+ facilities would cost $8-12B to replicate.
- Valuation discount to peers. 10x EV/EBITDA vs 15-18x for aggregates comps, despite higher ROE.
4.7 Key Catalysts
Positive:
- Mortgage rate decline -> housing starts recovery -> wallboard volume rebound
- Cement price increases ($8/ton announced for 2026)
- IIJA infrastructure spending ramp (60% of funds remaining)
- Duke plant completion (2H CY2027) -> 25% wallboard capacity at 20% lower cost
- Continued aggressive buybacks ($142M in Q3 FY2026 alone)
- Tariffs on cement imports benefiting domestic producers
Negative:
- Prolonged housing downturn (mortgage rates stay >6.5%)
- Recession reducing both residential and non-residential construction
- Leverage elevated at 1.8x after $750M notes issuance
- Energy cost inflation (cement is energy-intensive)
- Cyclical earnings peak already passed
Investment Verdict
Grade: B+ (High-Quality Cyclical)
Strengths: Exceptional capital allocation (20% share reduction, 28%+ ROE), irreplaceable physical assets with regional cost moats, dual-segment diversification, lean operations (3.3% SG&A ratio), strong infrastructure tailwinds for cement, Klarman conviction buy at higher prices.
Weaknesses: Deep cyclicality (EPS can drop 90% in severe downturn), commodity product with limited pricing power, wallboard in active downturn, elevated leverage post-$750M issuance, near-peak earnings make current valuation deceptive.
Recommendation: WAIT
At $201, EXP is moderately attractive but not a screaming buy. The stock trades at ~18x mid-cycle normalized earnings, which is fair-to-slightly-expensive for a cyclical. Klarman's conviction is notable (increasing at ~$200-240 levels), but his estimated cost basis of ~$238 means he bought too early.
The ideal entry is on further housing weakness or a broader market correction that pushes the stock toward $165-190. At those prices, you get a world-class capital allocator with irreplaceable assets at a genuine cyclical discount.
Strong Buy: $165 (15x mid-cycle EPS, ~25% margin of safety) Accumulate: $190 (17x mid-cycle EPS, ~15% margin of safety) Current: ~$201 (8.3x EV/EBITDA after recent debt adjust)
Analysis based on AlphaVantage financial data, EODHD market data, SEC filings, company press releases, and primary source research. No analyst reports used.